Table 2.
The top 10 enriched Gene Ontology terms of Differentially Expressed Genes (DEGs), sorted by P value in ascending order. On the basis of DEGs, the network analysis identified the modulated pathways are listed. All the genes are upregulated. The most commonly activated targetable genes are associated with FGF signaling pathways.
| # | Maps | Total | p-value | FDR | In Data | Network Objects from Active Data |
|---|---|---|---|---|---|---|
| 1 | Protein folding and maturation_POMC processing | 30 | 7.737E-21 | 3.474E-18 | 16 | CLIP, ACTH, alpha-MSH beta-Endorphin extracellular region, proACTH, POMC, N-POMC, gamma-MSH, N-POC, beta-LPH, gamma-LPH, ACTH 1-17, DA-alphaMSH, gamma2-MSH, gamma3-MSK beta-MSH |
| 2 | Development_FGF-family signaling | 52 | 1.569E-09 | 3.522E-07 | 11 | FGF2, FGF8, FGF9, FGF3, FGF7, FGF10, FGF6, FGF 19, FGFR1, FGF1, FGF4 |
| 3 | Neurophysiological process_Receptor-mediated axon growth repulsion | 46 | 1.650E-05 | 1.853E-03 | 7 | PlexinA2, Ephexin, F-Actin cytoskeleton, Fer, c-Fes, Plexin A1, Actin cytoskeletal |
| 4 | FGF signaling in pancreatic cancer | 46 | 1.650E-05 | 1.853E-03 | 7 | FGF2, FGF7, FGF5, FGF10, FGFR1, HBP17, FGF1 |
| 5 | Signal transduction_mTORC1 downstream signaling | 61 | 7.790E-04 | 6.996E-02 | 6 | 4E-BP2, CLIP170, 4E-BP1, LIPIN1, elF4A, elF4E |
| 6 | Development_Growth factors in regulation of oligodendrocyte precursor cell proliferation | 67 | 1.281 E-03 | 9.584E-02 | 6 | FGF2, FGF8, FGF18, FGF17, FGFR1, mTOR |
| 7 | Cytoskeleton remodeling_Reverse signaling by Ephrin-B | 32 | 2.494E-03 | 1.578E-01 | 4 | SDF-1, FAP-1, Actin cytoskeletal, F-Actin |
| 8 | Translation_Regulation of EIF4F activity | 54 | 2.812E-03 | 1.578E-01 | 5 | 4E-BP1, elF4A, elF4E, mTOR, elF4G2 |
| 9 | Androgen receptor activation and downstream signaling in Prostate cancer | 110 | 3.727E-03 | 1.859E-01 | 7 | FGF2, FGF8, SPRY2, ESR2, FGFR1, FEN1, FGF1 |
| 10 | Development_Mu-type opioid receptor signaling | 38 | 4.706E-03 | 1.951E-01 | 4 | 4E-BP2, beta-Endorphin extracellular region, 4E-BP1, mTOR |